Treatment Patterns and Real-world Evidence for Stage III Non-small Cell Lung Cancer in Central and Eastern Europe

Podobne zapisy

• Long-term Survival of Locally Advanced Stage III Non-small Cell Lung Cancer Patients Treated with Chemoradiotherapy and Perspectives for The Treatment with Immunotherapy
  od: Vrankar, Martina, i wsp.
  Wydane: (2018)
• Access to Novel Drugs for Non‐Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis
  od: Cufer, Tanja, i wsp.
  Wydane: (2019)
• Incorporation of EGFR Mutation Status into M Descriptor of New TNM Classification Influences Survival Curves in Non-small Cell Lung Cancer Patients
  od: Stanic, Karmen, i wsp.
  Wydane: (2019)
• Consolidation Radiotherapy for Patients with Extended Disease Small Cell Lung Cancer in a Single Tertiary Institution: Impact of Dose and Perspectives in the Era of Immunotherapy
  od: Stanic, Karmen, i wsp.
  Wydane: (2020)
• Prognostic value of PD-L1 expression in patients with unresectable stage III non-small cell lung cancer treated with chemoradiotherapy
  od: Vrankar, Martina, i wsp.
  Wydane: (2020)